Corient Private Wealth’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$63.1M Sell
535,672
-981,447
-65% -$121M 0.09% 202
2025
Q4
$191M Buy
1,517,119
+473,192
+45% +$61.7M 0.13% 160
2025
Q3
$153M Sell
1,043,927
-260,056
-20% -$39.3M 0.24% 87
2025
Q2
$203M Sell
1,303,983
-82,770
-6% -$13.1M 0.27% 65
2025
Q1
$228M Sell
1,386,753
-263,228
-16% -$43.8M 0.37% 58
2024
Q4
$269M Sell
1,649,981
-119,086
-7% -$21.3M 0.45% 45
2024
Q3
$346M Buy
1,769,067
+18,751
+1% +$3.45M 0.54% 34
2024
Q2
$303M Sell
1,750,316
-210,418
-11% -$35M 0.53% 34
2024
Q1
$332M Buy
1,960,734
+7,226
+0.4% +$1.35M 0.59% 34
2023
Q4
$386M Buy
1,953,508
+600,804
+44% +$106M 0.71% 29
2023
Q3
$235M Buy
1,352,704
+44,153
+3% +$8.02M 0.54% 36
2023
Q2
$225M Buy
1,308,551
+47,907
+4% +$8.28M 0.52% 38
2023
Q1
$210M Buy
1,260,644
+407,630
+48% +$66.8M 0.56% 37
2022
Q4
$125M Buy
+853,014
New +$126M 0.45% 54

Other funds holding ZTS

Corient Private Wealth's ZTS Position: Q1 2026 in Review

Corient Private Wealth reduced its Zoetis (ZTS) stake by 65% in Q1 2026, selling an estimated $121M and leaving 535,672 shares worth $63.1M. The position accounts for 0.09% of the portfolio, ranked #202.

Corient Private Wealth first reported a position in ZTS in Q4 2022 and has held it in 14 quarters since. The position peaked at $386M in Q4 2023. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Corient Private Wealth held 535,672 shares of Zoetis worth $63.1M as of Q1 2026.
  • Corient Private Wealth sold 981,447 Zoetis shares in Q1 2026, an estimated $121M.
  • Zoetis made up 0.09% of Corient Private Wealth's portfolio in Q1 2026, its #202 holding.
  • Corient Private Wealth first reported a position in Zoetis in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Zoetis position peaked at $386M in Q4 2023.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.